Securities and Exchange Act B.E. 2535 (1992). Clause 2. The auditor who is approved by the Office of the Securities and Exchange Commission under the Notification governing approval for auditor, and is

resolutions as following: (1) Approved the Balance Sheet and the Profits and Loss Statement as of 31 December 2019 (2) Approved the dividend payment from the company’s performance of the period 1 July – 31

approved. 2. That the connected transaction regarding the appointment of Ms. Suchada Sodthibhapkul, Authorized Director, as an Executive Director of the Company for the period from November 2018 to October

investors to carefully and prudently study the information from the complete version of summarized significant features of securities (Fact Sheet) to clearly understand the product and appraise own risk

ensure that investors would be informed of up-to-date, complete and sufficient information for investment decision-making in line with the globally recognized standards of the International Organization of

that the group of offerors were made aware of their duties and responsibilities to deliver a complete Form 247-4 to the shareholders, which is in violation of the Securities and Exchange Act B.E. 2535

to complete the rectification and review process. After considering the request, the SEC determined that CHARAN is in a position to complete the rectification within the prescribed deadline

15th June 2015 until the payment is complete. However, on 26th January 2018, the company appealed against the subordinate court. Then, on 25th March 2019, the Civil Court of Southern Bangkok read the

") Board of Directors' Meeting No. 9/2017, held on October 25, 2017, (the "Meeting"), the Company would like to announce the Board of Directors' significant resolutions as follows: 1. Approved to propose to

/2017 on December 12, 2017. The meeting unanimously approved significant matters as follows: 1. Approved the reduction of the Company’s registered capital by Baht 212.00 from the existing registered